A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis

Background: Pilot studies of interferon α (IFN-α) suggest a high remission rate in the treatment of active ulcerative colitis. We evaluated the safety of pegylated interferon α (PegIFN) and its role in induction of remission in patients with active ulcerative colitis, in a multicentre placebo contro...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tilg, H, Vogelsang, H, Ludwiczek, O, Lochs, H, Kaser, A, Colombel, J-F, Ulmer, H, Rutgeerts, P, Krüger, S, Cortot, A, D’Haens, G, Harrer, M, Gasche, C, Wrba, F, Kuhn, I, Reinisch, W
Médium: Artigo
Jazyk:Inglês
Vydáno: Copyright 2003 by Gut 2003
Témata:
Inflammatory Bowel Disease
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773891/
https://ncbi.nlm.nih.gov/pubmed/14633951
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky